EUVIMEDEUVIMED entdecken
Validierungsstudie

Prognostic value of combining clinical factors, 18F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation study

Kun-Han Lue, Yu-Hung Chen, Sung-Chao Chu, Chih-Bin Lin, Tso-Fu Wang, Shu-Hsin Liu

Annals of Nuclear Medicine · 2024

DOI: 10.1007/s12149-024-01936-2 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Annals of Nuclear Medicine, 2024. Verfasst von Kun-Han Lue und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging and Radiological Sciences, Tzu Chi University of Science and Technology, No.880, Sec.2, Chien-kuo Rd., Hualien, 970302,…. Hauptthemen laut MEDLINE: ErbB Receptors, Fluorodeoxyglucose F18, Lung Neoplasms, Mutation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Buddhist Tzu Chi Medical Foundation, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErbB ReceptorsFluorodeoxyglucose F18Lung NeoplasmsMutationAdenocarcinoma of LungDeep LearningHumansMaleFemaleMiddle AgedAgedPrognosisRetrospective StudiesMolecular Targeted TherapyPositron-Emission TomographyAdultProtein Kinase InhibitorsAged, 80 and over

Stichwörter der Autor:innen

18F-FDG PETDeep learningEpidermal growth factor receptorLung adenocarcinomaPrognosis

Substanzen

ErbB ReceptorsFluorodeoxyglucose F18EGFR protein, humanProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Medical Imaging and Radiological Sciences, Tzu Chi University of Science and Technology, No.880, Sec.2, Chien-kuo Rd., Hualien, 970302, Taiwan.
  • Department of Medical Imaging and Radiological Sciences, Tzu Chi University of Science and Technology, No.880, Sec.2, Chien-kuo Rd., Hualien, 970302, Taiwan. jedimasterchen@hotmail.com.
  • Department of Nuclear Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, No.707, Sec.3, Zhongyang Rd, Hualien, 970473, Taiwan. jedimasterchen@hotmail.com.
  • School of Medicine, College of Medicine, Tzu Chi University, No.701, Sec.3, Zhongyang Rd, Hualien, 970473, Taiwan. jedimasterchen@hotmail.com.
  • School of Medicine, College of Medicine, Tzu Chi University, No.701, Sec.3, Zhongyang Rd, Hualien, 970473, Taiwan.
  • Department of Hematology and Oncology, Buddhist Tzu Chi Medical Foundation, Hualien Tzu Chi Hospital, Hualien, Taiwan.

Förderung

  • Buddhist Tzu Chi Medical Foundation
  • National Science and Technology Council

Zitieren

APA

Lue, K. H., Chen, Y. H., Chu, S. C., Lin, C. B., Wang, T. F., & Liu, S. H. (2024). Prognostic value of combining clinical factors, 18F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation study. Annals of Nuclear Medicine. https://doi.org/10.1007/s12149-024-01936-2

Vancouver

Lue KH, Chen YH, Chu SC, Lin CB, Wang TF, Liu SH. Prognostic value of combining clinical factors, 18F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation study. Annals of Nuclear Medicine. 2024. doi:10.1007/s12149-024-01936-2

BibTeX
@article{Lue2024,
  author = {Lue, Kun-Han and Chen, Yu-Hung and Chu, Sung-Chao and Lin, Chih-Bin and Wang, Tso-Fu and Liu, Shu-Hsin},
  title = {Prognostic value of combining clinical factors, 18F-FDG PET-based intensity, volumetric features, and deep learning predictor in patients with EGFR-mutated lung adenocarcinoma undergoing targeted therapies: a cross-scanner and temporal validation study},
  journal = {Annals of Nuclear Medicine},
  year = {2024},
  doi = {10.1007/s12149-024-01936-2}
}
Kostenlos starten →